Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia

Yoshiyuki Kosaka, Hiroshi Yagasaki, Kimihiko Sano, Ryoji Kobayashi, Hiroshi Ayukawa, Takashi Kaneko, Hiromasa Yabe, Masahiro Tsuchida, Hideo Mugishima, Akira Ohara, Akira Morimoto, Yoshitoshi Otsuka, Shouichi Ohga, Fumio Bessho, Tatsutoshi Nakahata, Ichiro Tsukimoto, Seiji Kojima

Blood (2008) 111 (3): 1054–1059.

https://doi.org/10.1182/blood-2007-08-099168

Published: 2008

Includes: Supplemental data

Journal Articles

The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3

Hans-Jörg Bühring, Martina Seiffert, Christina Giesert, Anke Marxer, Lothar Kanz, Peter Valent, Kimihiko Sano

Blood (2001) 97 (10): 3303–3305.

https://doi.org/10.1182/blood.V97.10.3303

Published: 2001

Journal Articles

Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage leukemia protein in a therapy-related leukemia with t(3;11) (p21;q23)

Kimihiko Sano, Akira Hayakawa, Jin-Hua Piao, Yoshiyuki Kosaka, Hajime Nakamura

Blood (2000) 95 (3): 1066–1068.

https://doi.org/10.1182/blood.V95.3.1066.003k11_1066_1068

Published: 2000

Journal Articles

Effective Control of Epstein-Barr Virus–Related Hemophagocytic Lymphohistiocytosis With Immunochemotherapy

Blood (1999) 93 (6): 1869–1874.

https://doi.org/10.1182/blood.V93.6.1869.406a31_1869_1874

Published: 1999

Journal Articles

Elevation of the Serum Fas Ligand in Patients With Hemophagocytic Syndrome and Diamond-Blackfan Anemia

Daiichiro Hasegawa, Seiji Kojima, Eiji Tatsumi, Akira Hayakawa, Yoshiyuki Kosaka, Hajime Nakamura, Masahiro Sako, Yuko Osugi, Shigekazu Nagata, Kimihiko Sano

Blood (1998) 91 (8): 2793–2799.

https://doi.org/10.1182/blood.V91.8.2793.2793_2793_2799

Published: 1998

NARROW

Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia

The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3

Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage leukemia protein in a therapy-related leukemia with t(3;11) (p21;q23)

Effective Control of Epstein-Barr Virus–Related Hemophagocytic Lymphohistiocytosis With Immunochemotherapy

Elevation of the Serum Fas Ligand in Patients With Hemophagocytic Syndrome and Diamond-Blackfan Anemia

Email alerts

ASH Publications

American Society of Hematology

Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia

The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/phosphodiesterase 3

Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage leukemia protein in a therapy-related leukemia with t(3;11) (p21;q23)

Effective Control of Epstein-Barr Virus–Related Hemophagocytic Lymphohistiocytosis With Immunochemotherapy

Elevation of the Serum Fas Ligand in Patients With Hemophagocytic Syndrome and Diamond-Blackfan Anemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only